Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2001 1
2002 9
2003 7
2004 4
2005 3
2006 3
2007 2
2008 3
2009 1
2010 5
2011 5
2012 4
2013 3
2014 1
2015 1
2016 1
2017 1
2018 2
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Results by year
Filters applied: . Clear all
Page 1
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study.
Moss DJH, Pardiñas AF, Langbehn D, Lo K, Leavitt BR, Roos R, Durr A, Mead S; TRACK-HD investigators; REGISTRY investigators, Holmans P, Jones L, Tabrizi SJ. Moss DJH, et al. Lancet Neurol. 2017 Sep;16(9):701-711. doi: 10.1016/S1474-4422(17)30161-8. Epub 2017 Jun 20. Lancet Neurol. 2017. PMID: 28642124
BACKGROUND: Huntington's disease is caused by a CAG repeat expansion in the huntingtin gene, HTT. ...We generated a parallel progression score using data from 1773 previously genotyped participants from the European Huntington's Disease Network REGISTRY study of …
BACKGROUND: Huntington's disease is caused by a CAG repeat expansion in the huntingtin gene, HTT. ...We generated a parallel progress …
Huntington's disease.
Bonelli RM, Beal MF. Bonelli RM, et al. Handb Clin Neurol. 2012;106:507-26. doi: 10.1016/B978-0-444-52002-9.00030-9. Handb Clin Neurol. 2012. PMID: 22608641 Review. No abstract available.
Sexuality in Huntington's disease.
Schmidt EZ, Bonelli RM. Schmidt EZ, et al. Wien Med Wochenschr. 2008;158(3-4):78-83. doi: 10.1007/s10354-007-0477-8. Wien Med Wochenschr. 2008. PMID: 18330523 Review.
There are just a few studies in literature about sexuality in Huntington's disease which conclude that up to 85% men and up to 75% of women experience high levels of sexual problems, most of them having prevalent symptoms of a hypoactive sexual disorder but also increased …
There are just a few studies in literature about sexuality in Huntington's disease which conclude that up to 85% men and up to 75% of …
Frontal-subcortical dementias.
Bonelli RM, Cummings JL. Bonelli RM, et al. Neurologist. 2008 Mar;14(2):100-7. doi: 10.1097/NRL.0b013e31815b0de2. Neurologist. 2008. PMID: 18332839 Review.
It also has marked frontal dysfunction. Classic frontal-subcortical dementias include Huntington chorea, Parkinson disease dementia, progressive supranuclear palsy, thalamic degeneration, subcortical vascular dementia, multiple sclerosis, the acquired immunodeficiency synd …
It also has marked frontal dysfunction. Classic frontal-subcortical dementias include Huntington chorea, Parkinson disease dementia, …
Huntington's disease and minocycline.
Hödl AK, Bonelli RM. Hödl AK, et al. Mov Disord. 2005 Apr;20(4):510-511. doi: 10.1002/mds.20441. Mov Disord. 2005. PMID: 15806589 No abstract available.
Huntington's disease: present treatments and future therapeutic modalities.
Bonelli RM, Wenning GK, Kapfhammer HP. Bonelli RM, et al. Int Clin Psychopharmacol. 2004 Mar;19(2):51-62. doi: 10.1097/00004850-200403000-00001. Int Clin Psychopharmacol. 2004. PMID: 15076012 Review.
Huntington's disease (HD) is a devastating neuropsychiatric disorder for which therapeutic interventions have been rather fruitless to date, except in a slight symptomatic relief. ...
Huntington's disease (HD) is a devastating neuropsychiatric disorder for which therapeutic interventions have been rather fruitless t
Pharmacological management of Huntington's disease: an evidence-based review.
Bonelli RM, Wenning GK. Bonelli RM, et al. Curr Pharm Des. 2006;12(21):2701-20. doi: 10.2174/138161206777698693. Curr Pharm Des. 2006. PMID: 16842168 Review.
INTRODUCTION: Despite the increasing body of published reports on pharmacological interventions in Huntington's disease (HD), an evidence based review (EBR) of treatment studies has not yet been published. ...
INTRODUCTION: Despite the increasing body of published reports on pharmacological interventions in Huntington's disease (HD), an evid …
A systematic review of the treatment studies in Huntington's disease since 1990.
Bonelli RM, Hofmann P. Bonelli RM, et al. Expert Opin Pharmacother. 2007 Feb;8(2):141-53. doi: 10.1517/14656566.8.2.141. Expert Opin Pharmacother. 2007. PMID: 17257085 Review.
Huntington's disease (HD) is an autosomal dominant, inherited, neuropsychiatric disease that gives rise to progressive motor, cognitive and behavioural symptoms. ...
Huntington's disease (HD) is an autosomal dominant, inherited, neuropsychiatric disease that gives rise to progressive motor, cogniti
A review of the treatment options for Huntington's disease.
Bonelli RM, Hofmann P. Bonelli RM, et al. Expert Opin Pharmacother. 2004 Apr;5(4):767-76. doi: 10.1517/14656566.5.4.767. Expert Opin Pharmacother. 2004. PMID: 15102562 Review.
Huntington's disease (HD) is an autosomal dominant, inherited, neuropsychiatric disease which gives rise to progressive motor, cognitive and behavioural symptoms. ...
Huntington's disease (HD) is an autosomal dominant, inherited, neuropsychiatric disease which gives rise to progressive motor, cognit
Frontal-subcortical circuitry and behavior.
Bonelli RM, Cummings JL. Bonelli RM, et al. Dialogues Clin Neurosci. 2007;9(2):141-51. doi: 10.31887/DCNS.2007.9.2/rbonelli. Dialogues Clin Neurosci. 2007. PMID: 17726913 Free PMC article. Review.
A variety of other neuropsychiatric disorders, such as Tourette's syndrome, Huntington's disease, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, schizophrenia, and mood disorders may result from disturbances that have a direct or indirect impact o …
A variety of other neuropsychiatric disorders, such as Tourette's syndrome, Huntington's disease, obsessive-compulsive disorder, atte …
54 results